Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Clarithromycin Citrate (1:1)
2. 16k08r7ng0
3. Erythromycin, 6-o-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (salt) (1:1)
4. 848130-51-8
5. Unii-16k08r7ng0
6. Schembl6275870
7. Clarithromycin Citrate [who-dd]
8. Q27251822
| Molecular Weight | 940.1 g/mol |
|---|---|
| Molecular Formula | C44H77NO20 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 21 |
| Rotatable Bond Count | 13 |
| Exact Mass | 939.50389385 g/mol |
| Monoisotopic Mass | 939.50389385 g/mol |
| Topological Polar Surface Area | 315 Ų |
| Heavy Atom Count | 65 |
| Formal Charge | 0 |
| Complexity | 1420 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A UNII-16K08R7NG0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of UNII-16K08R7NG0, including repackagers and relabelers. The FDA regulates UNII-16K08R7NG0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. UNII-16K08R7NG0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A UNII-16K08R7NG0 supplier is an individual or a company that provides UNII-16K08R7NG0 active pharmaceutical ingredient (API) or UNII-16K08R7NG0 finished formulations upon request. The UNII-16K08R7NG0 suppliers may include UNII-16K08R7NG0 API manufacturers, exporters, distributors and traders.
click here to find a list of UNII-16K08R7NG0 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A UNII-16K08R7NG0 written confirmation (UNII-16K08R7NG0 WC) is an official document issued by a regulatory agency to a UNII-16K08R7NG0 manufacturer, verifying that the manufacturing facility of a UNII-16K08R7NG0 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting UNII-16K08R7NG0 APIs or UNII-16K08R7NG0 finished pharmaceutical products to another nation, regulatory agencies frequently require a UNII-16K08R7NG0 WC (written confirmation) as part of the regulatory process.
click here to find a list of UNII-16K08R7NG0 suppliers with Written Confirmation (WC) on PharmaCompass.
UNII-16K08R7NG0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of UNII-16K08R7NG0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right UNII-16K08R7NG0 GMP manufacturer or UNII-16K08R7NG0 GMP API supplier for your needs.
A UNII-16K08R7NG0 CoA (Certificate of Analysis) is a formal document that attests to UNII-16K08R7NG0's compliance with UNII-16K08R7NG0 specifications and serves as a tool for batch-level quality control.
UNII-16K08R7NG0 CoA mostly includes findings from lab analyses of a specific batch. For each UNII-16K08R7NG0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
UNII-16K08R7NG0 may be tested according to a variety of international standards, such as European Pharmacopoeia (UNII-16K08R7NG0 EP), UNII-16K08R7NG0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (UNII-16K08R7NG0 USP).
LOOKING FOR A SUPPLIER?
